COVID-19 research campaign moves from basic science to antiviral drug design

ORNL researchers have developed and tested novel small-molecule antivirals in an effort to design new drugs to treat COVID-19. The so called hybrid inhibitor molecules are made from repurposed drugs used to treat hepatitis C and the original coronavirus outbreak in the early 2000s. The experimental research results show the molecules are similarly as effective as some of the leading drugs on the market today.

Tracking Pileups on Battery Charging Route to Drive Performance

An understanding of this mechanism could help scientists increase the total amount of energy stored by next-generation lithium-ion batteries.

Automatically Steering Experiments Toward Scientific Discovery

Scientists at Brookhaven and Lawrence Berkeley National Laboratories have been developing an automated experimental setup of data collection, analysis, and decision making.

Uncovering Hidden Local States in a Quantum Material

States of local broken symmetry at high temperature—observed in several materials, including one with a metal-insulator transition, an iron-based superconductor, and an insulating mineral part of the Earth’s upper mantle—may enable the technologically relevant properties arising at much-lower temperature.

Exploring Blended Materials Along Compositional Gradients

A new platform could accelerate the development of blended materials with desired properties.

At the Interface of Organic Chemistry and Nanotechnology with Adam Braunschweig

Adam Braunschweig—a CUNY ASRC associate professor—is a user at Brookhaven Lab’s Center for Functional Nanomaterials (CFN) studying how molecules in organic semiconductor thin films pack together.

Transforming Advanced Nanoscience Data into Interactive Art

A scientist, an artist, and a computer music professor combined 3-D printing, sound, and virtual reality to represent nanoscience data.